Page last updated: 2024-08-25

ropivacaine and Adenocarcinoma of Lung

ropivacaine has been researched along with Adenocarcinoma of Lung in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baek, S; Bang, S; Chung, J; Chung, K; Lee, SM; Yoo, S1
Beck-Schimmer, B; Borgeat, A; Dull, RO; Minshall, RD; Piegeler, T; Schläpfer, M; Schwartz, DE1

Other Studies

2 other study(ies) available for ropivacaine and Adenocarcinoma of Lung

ArticleYear
The erector spinae plane block for effective analgesia after lung lobectomy: Three cases report.
    Medicine, 2019, Volume: 98, Issue:29

    Topics: Adenocarcinoma of Lung; Adjuvants, Anesthesia; Aged; Analgesia, Patient-Controlled; Anesthetics, Local; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Middle Aged; Nerve Block; Pain Management; Pain, Postoperative; Paraspinal Muscles; Pneumonectomy; Ropivacaine; Thoracoscopy; Treatment Outcome; Ultrasonography, Interventional

2019
Clinically relevant concentrations of lidocaine and ropivacaine inhibit TNFα-induced invasion of lung adenocarcinoma cells in vitro by blocking the activation of Akt and focal adhesion kinase.
    British journal of anaesthesia, 2015, Volume: 115, Issue:5

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Amides; Anesthetics, Local; Caveolin 1; Cell Movement; Drug Evaluation, Preclinical; Enzyme Activation; Focal Adhesion Protein-Tyrosine Kinases; Humans; Lidocaine; Lung Neoplasms; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Proteins; Phosphorylation; Proto-Oncogene Proteins c-akt; Ropivacaine; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2015